The Effects of Anti-bile Reflux Treatment on Helicobacter pylori Infection in Gastric Mucosa

褚传莲,李延青,张燕,李文婕,赵宪邨

DOI: https://doi.org/10.3969/j.issn.1008-7125.2002.06.010

2002-01-01

Abstract:Background: It is generally known that bile acid can inhibit the growth of Helicobacter pylori (H. pylori) in vitro, but the effect of bile reflux on H. pylori in vivo is uncertain. Aims: To investigate the effects of anti-bile reflux treatment on H. pylori infection in gastric mucosa. Methods: Fifty patients with chronic gastritis and bile reflux identified by upper gastrointestinal endoscopy were recruited and treated with hydrotalcite tablets 1 000 mg, three times a day for four weeks. At gastroscopy three biopsy specimens in each patient were obtained from the antral mucosa for histopathological examination and rapid urease test (RUT) before and after treatment. The status of H. pylori infection was detected by Giemsa staining, RUT or serum H. pylori-IgG antibodies. Results: The H. pylori infection rate before treatment was 66.0%; there was no difference between H. pylori infection and bile reflux rate grade I , II and III. Forty-eight patients were followed up. The degree of bile reflux decreased significantly after treatment, but the incidence of H. pylori infection (64.6%) was not influenced by anti-bile reflux treatment. The activity of gastritis was more common in patients with H. pylori infection. The rate of intestinal metaplasia in gastric mucosa in patients with H. pylori infection was also significantly higher than that in patients without H. pylori infection (39.4% vs 11.8%, P<0.05). Conclusions: Patients with both H. pylori infection and bile reflux suffer from more serious gastritis, and the intestinal metaplasia rate in these patients is higher than that in those without H. pylori infection. Anti-bile reflux treatment is effective in inhibiting bile reflux, but has no effect on H. pylori infection in gastric mucosa.